Eur Respir J 1997; 10:2529-2534 Copyright ©ERS Journals Ltd 1997
Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer
T Bury,
A Dowlati,
P Paulus,
JL Corhay,
R Hustinx,
B Ghaye,
M Radermecker,
and
P Rigo
Despite advances in morphological imaging, some patients with lung cancer are found to have nonresectable disease at surgery or die of recurrence within yr of surgery. We performed a prospective study in 109 patients to compare the accuracy of whole-body positron emission tomography (PET) using fluorine-18 deoxyglucose (18FDG) and conventional imaging (CI) methods for the staging of non-small cell lung cancer (NSCLC). When CI or PET study suggested metastatic disease, confirmation was obtained by biopsy or follow-up information. As compared to CI, 18FDG-PET correctly changed the N stage in 22 patients (33%) and the M stage in 15 patients (14%). For the detection of distant metastases, PET study showed five false-positive sites and no false-negative cases. Currently, the accuracy of PET in the detection of M stage is 96%. Our study shows that visual interpretation of whole-body fluorine-18 deoxyglucose-positron emission tomography images can improve the diagnostic accuracy in the staging of non-small cell lung cancer. Further experience is needed to establish if metabolic imaging would be a cost-effective tool in the future management of lung cancer.
This article has been cited by other articles:

|
 |

|
 |
 
D. Uesaka, Y. Demura, T. Ishizaki, S. Ameshima, I. Miyamori, M. Sasaki, Y. Fujibayashi, and H. Okazawa
Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer
J. Nucl. Med.,
October 1, 2008;
49(10):
1606 - 1612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst,
December 5, 2007;
99(23):
1753 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest,
September 1, 2007;
132(3_suppl):
178S - 201S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Birim, A. P. Kappetein, T. Stijnen, and A. J.J.C. Bogers
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer
Ann. Thorac. Surg.,
January 1, 2005;
79(1):
375 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist,
November 1, 2004;
9(6):
633 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Schaffler, G. Wolf, H. Schoellnast, R. Groell, A. Maier, F. M. Smolle-Juttner, M. Woltsche, G. Fasching, R. Nicoletti, and R. M. Aigner
Non-Small Cell Lung Cancer: Evaluation of Pleural Abnormalities on CT Scans with 18F FDG PET
Radiology,
June 1, 2004;
231(3):
858 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Duysinx, D. Nguyen, R. Louis, D. Cataldo, T. Belhocine, P. Bartsch, and T. Bury
Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
Chest,
February 1, 2004;
125(2):
489 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens
Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis
Ann Intern Med,
December 2, 2003;
139(11):
879 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Toloza, L. Harpole, and D. C. McCrory
Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
Chest,
January 1, 2003;
123
(2009):
137S - 146S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A G Pitman, R J Hicks, D S Binns, R E Ware, V Kalff, A F McKenzie, D L Ball, and M P MacManus
Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
Br. J. Radiol.,
February 1, 2002;
75(890):
114 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Laking and P Price
18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
Thorax,
September 1, 2001;
56(90002):
ii38 - 44.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Jager, H. J.M. Groen, A. van der Leest, J. W.G. van Putten, R. M. Pieterman, E. G.E. de Vries, and D. A. Piers
L-3-[123I]Iodo-{{alpha}}-Methyl-Tyrosine SPECT in Non-Small Cell Lung Cancer: Preliminary Observations
J. Nucl. Med.,
April 1, 2001;
42(4):
579 - 585.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M.A. Daniels, H. Rijna, P. E. Postmus, and J. C. van Mourik
Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell lung carcinoma
Eur. J. Cardiothorac. Surg.,
March 1, 2001;
19(3):
377 - 378.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Dunagan, R. Chin Jr., T. W. McCain, L. D. Case, B. A. Harkness, T. Oaks, and E. F. Haponik
Staging by Positron Emission Tomography Predicts Survival in Patients With Non-small Cell Lung Cancer
Chest,
February 1, 2001;
119(2):
333 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kalff, R. J. Hicks, M. P. MacManus, D. S. Binns, A. F. McKenzie, R. E. Ware, A. Hogg, and D. L. Ball
Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study
J. Clin. Oncol.,
January 1, 2001;
19(1):
111 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bousson, J.-L. Moretti, P. Weinmann, N. Safi, F. Tamgac, C. Groiselle, V. de Beco, Y. Hillali, D. Valeyre, and J.-L. Breau
Assessment of Malignancy in Pulmonary Lesions: FDG Dual-Head Coincidence Gamma Camera Imaging in Association with Serum Tumor Marker Measurement
J. Nucl. Med.,
November 1, 2000;
41(11):
1801 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Marom, H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz Jr
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Radiology,
September 1, 1999;
212(3):
803 - 809.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. M. Graeber, N. C. Gupta, and G. F. Murray
POSITRON EMISSION TOMOGRAPHIC IMAGING WITH FLUORODEOXYGLUCOSE IS EFFICACIOUS IN EVALUATING MALIGNANT PULMONARY DISEASE
J. Thorac. Cardiovasc. Surg.,
April 1, 1999;
117(4):
719 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|
|